BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2000 related articles for article (PubMed ID: 32558485)

  • 1. Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
    ; Ellinghaus D; Degenhardt F; Bujanda L; Buti M; Albillos A; Invernizzi P; Fernández J; Prati D; Baselli G; Asselta R; Grimsrud MM; Milani C; Aziz F; Kässens J; May S; Wendorff M; Wienbrandt L; Uellendahl-Werth F; Zheng T; Yi X; de Pablo R; Chercoles AG; Palom A; Garcia-Fernandez AE; Rodriguez-Frias F; Zanella A; Bandera A; Protti A; Aghemo A; Lleo A; Biondi A; Caballero-Garralda A; Gori A; Tanck A; Carreras Nolla A; Latiano A; Fracanzani AL; Peschuck A; Julià A; Pesenti A; Voza A; Jiménez D; Mateos B; Nafria Jimenez B; Quereda C; Paccapelo C; Gassner C; Angelini C; Cea C; Solier A; Pestaña D; Muñiz-Diaz E; Sandoval E; Paraboschi EM; Navas E; García Sánchez F; Ceriotti F; Martinelli-Boneschi F; Peyvandi F; Blasi F; Téllez L; Blanco-Grau A; Hemmrich-Stanisak G; Grasselli G; Costantino G; Cardamone G; Foti G; Aneli S; Kurihara H; ElAbd H; My I; Galván-Femenia I; Martín J; Erdmann J; Ferrusquía-Acosta J; Garcia-Etxebarria K; Izquierdo-Sanchez L; Bettini LR; Sumoy L; Terranova L; Moreira L; Santoro L; Scudeller L; Mesonero F; Roade L; Rühlemann MC; Schaefer M; Carrabba M; Riveiro-Barciela M; Figuera Basso ME; Valsecchi MG; Hernandez-Tejero M; Acosta-Herrera M; D'Angiò M; Baldini M; Cazzaniga M; Schulzky M; Cecconi M; Wittig M; Ciccarelli M; Rodríguez-Gandía M; Bocciolone M; Miozzo M; Montano N; Braun N; Sacchi N; Martínez N; Özer O; Palmieri O; Faverio P; Preatoni P; Bonfanti P; Omodei P; Tentorio P; Castro P; Rodrigues PM; Blandino Ortiz A; de Cid R; Ferrer R; Gualtierotti R; Nieto R; Goerg S; Badalamenti S; Marsal S; Matullo G; Pelusi S; Juzenas S; Aliberti S; Monzani V; Moreno V; Wesse T; Lenz TL; Pumarola T; Rimoldi V; Bosari S; Albrecht W; Peter W; Romero-Gómez M; D'Amato M; Duga S; Banales JM; Hov JR; Folseraas T; Valenti L; Franke A; Karlsen TH
    N Engl J Med; 2020 Oct; 383(16):1522-1534. PubMed ID: 32558485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.
    Valenti L; Griffini S; Lamorte G; Grovetti E; Uceda Renteria SC; Malvestiti F; Scudeller L; Bandera A; Peyvandi F; Prati D; Meroni P; Cugno M
    J Autoimmun; 2021 Feb; 117():102595. PubMed ID: 33453462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
    Gemmati D; Tisato V
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis.
    Liu N; Zhang T; Ma L; Zhang H; Wang H; Wei W; Pei H; Li H
    Blood Rev; 2021 Jul; 48():100785. PubMed ID: 33309392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.
    Downes DJ; Cross AR; Hua P; Roberts N; Schwessinger R; Cutler AJ; Munis AM; Brown J; Mielczarek O; de Andrea CE; Melero I; ; Gill DR; Hyde SC; Knight JC; Todd JA; Sansom SN; Issa F; Davies JOJ; Hughes JR
    Nat Genet; 2021 Nov; 53(11):1606-1615. PubMed ID: 34737427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1.
    Fink-Baldauf IM; Stuart WD; Brewington JJ; Guo M; Maeda Y
    EBioMedicine; 2022 Jan; 75():103806. PubMed ID: 34998241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics Insight for COVID-19 Susceptibility and Severity: A Review.
    Fricke-Galindo I; Falfán-Valencia R
    Front Immunol; 2021; 12():622176. PubMed ID: 33868239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
    Zeberg H; Pääbo S
    Nature; 2020 Nov; 587(7835):610-612. PubMed ID: 32998156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A poisoned gift].
    Jordan B
    Med Sci (Paris); 2020 Dec; 36(12):1233-1236. PubMed ID: 33296644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profiling identifies novel proteins for genetic risk of severe COVID-19: the Atherosclerosis Risk in Communities Study.
    Steffen BT; Pankow JS; Lutsey PL; Demmer RT; Misialek JR; Guan W; Cowan LT; Coresh J; Norby FL; Tang W
    Hum Mol Genet; 2022 Jul; 31(14):2452-2461. PubMed ID: 35212764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants associated with SARS-CoV-2 infection also affect lung function and asthma severity.
    Silva MJ; de Andrade CM; Fiuza BSD; Pinheiro GP; Nova Santana CV; Costa RDS; Barnes K; Cruz ÁA; Figueiredo CA
    Heliyon; 2023 Sep; 9(9):e19235. PubMed ID: 37662742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biological correlates associated with respiratory failure in COVID-19.
    Oh JH; Tannenbaum A; Deasy JO
    BMC Med Genomics; 2020 Dec; 13(1):186. PubMed ID: 33308225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.
    Shelton JF; Shastri AJ; Ye C; Weldon CH; Filshtein-Sonmez T; Coker D; Symons A; Esparza-Gordillo J; ; Aslibekyan S; Auton A
    Nat Genet; 2021 Jun; 53(6):801-808. PubMed ID: 33888907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host Genetic Factors, Comorbidities and the Risk of Severe COVID-19.
    Zhu D; Zhao R; Yuan H; Xie Y; Jiang Y; Xu K; Zhang T; Chen X; Suo C
    J Epidemiol Glob Health; 2023 Jun; 13(2):279-291. PubMed ID: 37160831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19.
    Yao Y; Ye F; Li K; Xu P; Tan W; Feng Q; Rao S
    Signal Transduct Target Ther; 2021 Feb; 6(1):85. PubMed ID: 33619245
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the genetic risk for COVID-19 outcomes in COPD and differences among worldwide populations.
    Marçalo R; Neto S; Pinheiro M; Rodrigues AJ; Sousa N; Santos MAS; Simão P; Valente C; Andrade L; Marques A; Moura GR
    PLoS One; 2022; 17(2):e0264009. PubMed ID: 35196333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO blood groups, COVID-19 infection and mortality.
    Lehrer S; Rheinstein PH
    Blood Cells Mol Dis; 2021 Jul; 89():102571. PubMed ID: 33894687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.
    Nishida N; Sugiyama M; Kawai Y; Naka I; Iwamoto N; Suzuki T; Suzuki M; Miyazato Y; Suzuki S; Izumi S; Hojo M; Tsuchiura T; Ishikawa M; Ohashi J; Ohmagari N; Tokunaga K; Mizokami M
    Sci Rep; 2022 Mar; 12(1):3854. PubMed ID: 35264675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.
    Mousa M; Vurivi H; Kannout H; Uddin M; Alkaabi N; Mahboub B; Tay GK; Alsafar HS;
    EBioMedicine; 2021 Dec; 74():103695. PubMed ID: 34775353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan.
    Fan Q; Zhang W; Li B; Li DJ; Zhang J; Zhao F
    Front Cell Infect Microbiol; 2020; 10():404. PubMed ID: 32793517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 100.